In the Health Affair Blog, Vikas Sukhatme, Kathy Fang, Andrew Lo, and Vidula Sukhatme from Harvard and the MIT have posted a very interesting note entitled : Financial Orphan Therapies Looking For Adoption where they introduce the concept of «financial orphans drugs.» The authors first review briefly the process of drug development today and its relatd issues (cost, risk ect...) and then expose the 4 categories of FOD : 1) New drug with IP protection with small market size or poor (...)